JPMorgan Chase & Co. Purchases 377,915 Shares of Mirion Technologies, Inc. (NYSE:MIR)

JPMorgan Chase & Co. increased its holdings in Mirion Technologies, Inc. (NYSE:MIR - Free Report) by 171.7% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 598,048 shares of the company's stock after acquiring an additional 377,915 shares during the quarter. JPMorgan Chase & Co. owned about 0.26% of Mirion Technologies worth $10,436,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in MIR. FMR LLC boosted its holdings in shares of Mirion Technologies by 258.4% during the 3rd quarter. FMR LLC now owns 17,957 shares of the company's stock valued at $199,000 after acquiring an additional 12,947 shares during the last quarter. State Street Corp lifted its stake in shares of Mirion Technologies by 2.7% during the 3rd quarter. State Street Corp now owns 5,365,728 shares of the company's stock valued at $59,399,000 after buying an additional 138,648 shares in the last quarter. XTX Topco Ltd bought a new stake in shares of Mirion Technologies during the third quarter valued at approximately $303,000. Barclays PLC lifted its stake in Mirion Technologies by 325.0% in the 3rd quarter. Barclays PLC now owns 307,680 shares of the company's stock worth $3,405,000 after purchasing an additional 235,288 shares in the last quarter. Finally, Geode Capital Management LLC boosted its stake in Mirion Technologies by 3.4% during the third quarter. Geode Capital Management LLC now owns 4,502,455 shares of the company's stock valued at $49,851,000 after buying an additional 147,408 shares during the last quarter. Institutional investors own 78.51% of the company's stock.

Analysts Set New Price Targets

MIR has been the topic of a number of recent analyst reports. B. Riley reduced their price objective on shares of Mirion Technologies from $19.00 to $17.00 and set a "buy" rating on the stock in a research report on Wednesday. Citigroup reduced their target price on Mirion Technologies from $20.00 to $17.00 and set a "buy" rating for the company in a research note on Monday, April 14th. Finally, Robert W. Baird decreased their price objective on Mirion Technologies from $22.00 to $20.00 and set an "outperform" rating for the company in a report on Friday, April 4th. Four research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. According to MarketBeat, Mirion Technologies presently has an average rating of "Buy" and a consensus price target of $18.75.

Mirion Technologies Stock Down 0.4 %

NYSE MIR traded down $0.05 during trading hours on Friday, hitting $13.79. The company had a trading volume of 914,653 shares, compared to its average volume of 1,668,099. The company has a market capitalization of $3.20 billion, a price-to-earnings ratio of -72.56 and a beta of 0.75. The company has a debt-to-equity ratio of 0.43, a current ratio of 2.16 and a quick ratio of 1.55. The firm's 50 day moving average is $14.72 and its 200 day moving average is $15.52. Mirion Technologies, Inc. has a fifty-two week low of $9.11 and a fifty-two week high of $18.81.

Mirion Technologies (NYSE:MIR - Get Free Report) last announced its quarterly earnings data on Tuesday, February 11th. The company reported $0.16 earnings per share for the quarter, beating the consensus estimate of $0.14 by $0.02. Mirion Technologies had a positive return on equity of 4.78% and a negative net margin of 4.21%. Sell-side analysts anticipate that Mirion Technologies, Inc. will post 0.39 earnings per share for the current fiscal year.

Mirion Technologies Profile

Mirion Technologies, Inc provides radiation detection, measurement, analysis, and monitoring products and services in the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, Netherlands, Estonia, South Korea, and Japan. It operates through two segments, Medical and Technologies.